Table 3.
HCV/HIV status among participants at the Miami IDEA syringe exchange
| Characteristics | Sample total n (%) | Fixed site n (%) | Mobile van unit n (%) | p value |
|---|---|---|---|---|
| Total | 718 (100.0) | 591 (82.3) | 127 (17.7) | |
| Prior HCV status | ||||
| Negative | 340 (54.2) | 304 (56.1) | 36 (42.9) | 0.040 |
| Positive | 266 (42.4) | 222 (41.0) | 44 (52.4) | |
| Unknown | 21 (3.3) | 16 (3.0) | 5 (5.9) | |
| HCV test result | ||||
| Positive | 69 (28.5) | 59 (27.6) | 10 (35.7) | 0.370 |
| Negative | 173 (71.5) | 155 (72.4) | 18 (64.3) | |
| Prior HIV status | ||||
| Negative | 584 (88.1) | 516 (88.7) | 68 (83.95) | 0.412 |
| Positive | 70 (10.6) | 58 (10.0) | 12 (14.81) | |
| Unknown | 9 (1.4) | 8 (1.4) | 1 (1.23) | |
| HIV test result | ||||
| Positive | 2 (0.6) | 2 (0.70) | 0 (0.0) | 0.608 |
| Negative | 344 (99.4) | 304 (99.4) | 40 (100.0) | |
| Currently in HIV treatment, if HIV positive | ||||
| Yes | 48 (82.8) | 39 (83.0) | 9 (81.8) | 0.927 |
| No | 10 (17.2) | 8 (17.0) | 2 (18.2) | |